High-Risk Localized Prostate Cancer: Clinical Trials

1 trial for High-Risk Localized Prostate Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow High-Risk Localized Prostate Cancer: new trials by email Literature Review of High-Risk Localized Prostate Cancer trials Research Report on High-Risk Localized Prostate Cancer

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RYZ711 Diagnostic Platform Study
RYZ711, PSMA PET/CT - Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate
Phase 1 / Phase 2Not yet recruitingRayzeBio, Inc.1162026-10-012026-10-26

Narrower conditions

Adenocarcinoma (1)  ·  Prostatic Neoplasms (1)

Broader conditions

Carcinoma (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Prostatic Diseases (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)

Sponsors

RayzeBio, Inc. (1)

Countries

United States (1)